Connect with us

Technology

PreemptiveAI Emerges From Stealth With a Groundbreaking Biomedical Foundation Model For Health Prediction

Published

on

SEATTLE, March 6, 2024 /PRNewswire/ — PreemptiveAI, an innovative AI research and development company driven by a mission to extend human life and boasting multiple scientific breakthroughs, is thrilled to announce its emergence from stealth mode. Based in Seattle, WA and backed by an initial $6.4M in funding, the company is unveiling a revolutionary foundation model aimed at transforming health prediction and monitoring. This model leverages advanced signal processing to interpret biomedical signals from smartphones and wearable devices, offering unprecedented insights into human physiology.

Led by a trio of multidisciplinary founders—Jamien McCullum, Leon Gatys, and Matt Whitehill—the company draws on Gatys’s experience as a co-founder of Apple’s AI health division and Whitehill’s doctoral research in health sensors under the guidance of Shwetak Patel, a leader in on-device deep learning and health technologies. PreemptiveAI’s breakthroughs extend the capabilities of Photoplethysmography (PPG) signals, commonly used for measuring vital signs, to provide a deep window into the body’s physiological state. This innovative approach not only facilitates early disease detection but also has far-reaching implications for patient care, precision medicine, and drug development.
The company’s journey, supported by the Paul Allen AI Institute and leading investors like Inspired Capital, Meridian Street Capital, and Precursor Ventures, has led to a strategic partnership with Duke University. This collaboration aims to enhance the model’s predictive capabilities, particularly in predicting hospital readmissions and identifying rising health risks. Dr. Lana Wahid of Duke University, now Medical Director of Duke’s Early Phase Research Unit, praises PreemptiveAI for its potential to significantly improve healthcare outcomes and efficiency.

“PreemptiveAI represents a monumental leap forward in our pursuit of transformative healthcare. Their technology is the catalyst we’ve needed to shift paradigms, providing a clear route to enhance patient care, improve outcomes, and drive significant cost savings. PreemptiveAI is building the foundation for a new era in medical excellence, and I’m proud to collaborate towards that vision,” says Dr. Wahid. 

PreemptiveAI’s founding team, with their deep expertise in wearable sensing technology, digital health, and machine learning, is dedicated to advancing healthcare through AI-driven innovations. As PreemptiveAI prepares for further commercial deployments in 2024, it continues to strengthen its model through partnerships across various healthcare sectors. The company is poised to redefine health diagnosis and management, marking a new era in medical excellence and preemptive health care.

About PreemptiveAI

PreemptiveAI, led by innovators Jamien McCullum, Leon Gatys, and Matt Whitehill, leverages Gatys’s insights from co-founding Apple’s AI health division and Whitehill’s expertise in health sensors, guided by Shwetak Patel’s pioneering work in on-device deep learning and health technologies. The company is advancing healthcare with its foundation model that intricately maps human physiology by interpreting biomedical signals from smartphones and wearable devices for unparalleled real-time health diagnosis and prediction. Incubated at the Paul Allen AI Institute in Seattle and recognized for its breakthroughs and a key partnership with Duke University, PreemptiveAI is reshaping healthcare with cutting-edge AI technology, highlighting its commitment to transformative healthcare solutions. To learn more, visit www.preemptiveai.com.

Media Contact: 
anathan@preemptiveai.com

View original content to download multimedia:https://www.prnewswire.com/news-releases/preemptiveai-emerges-from-stealth-with-a-groundbreaking-biomedical-foundation-model-for-health-prediction-302081718.html

SOURCE PreemptiveAI

Continue Reading
Click to comment

Leave a Reply

Your email address will not be published. Required fields are marked *

Technology

Dana-Farber Cancer Institute Partners with Clinical.ly to Enhance Regulatory Operations with eReg Solutions

Published

on

By

NEW YORK, Sept. 19, 2024 /PRNewswire/ — The Dana-Farber Cancer Institute, a world leader in cancer treatment and research, chose Clinical.ly’s (www.clinical.ly) Research Suite™ to streamline regulatory operations, marking a significant step toward more efficient and compliant clinical trial management. Dana-Farber joins a growing number of research organizations that leverage Clinical.ly’s innovative solutions to streamline clinical trial processes. Clinical.ly’s eReg platform offers a comprehensive, paperless solution that centralizes regulatory workflows, ensuring compliance and transparency across clinical trials.

“We are thrilled to support Dana-Farber’s clinical research operations,” said Henry Kravchenko, Clinical.ly’s CEO.

This partnership continues Clinical.ly’s success in providing best-in-class enterprise tools for conducting clinical research. “We are thrilled to support Dana-Farber’s clinical research operations,” said Henry Kravchenko, Clinical.ly’s CEO. “Our eReg platform and wider set of features in Clinical.ly Research Suite™ will empower that renowned organization, and we all look forward to supporting their teams.”

About Clinical.ly Research Suite™ 

Clinical.ly Research Suite™ is a comprehensive solution that eliminates traditional, paper-based processes. By automating and centralizing essential workflows in the Clinical.ly Research Suite™, organizations achieve huge efficiency improvements, greater trial oversight, document management, and regulatory compliance. The Clinical.ly Research Suite™ includes:

eReg: A best-in-class electronic regulatory bindereSource: An intuitive & feature-rich, paperless data capture solution that streamlines data collection from trial participantseConsent: A fully digital solution for capturing informed consent, improving participant engagement and site complianceClinicallySign: 21 CFR Part 11 compliant eSignature functionalityClinicallyPay: A secure and instantaneous participant stipend payment and reimbursement solution

About Dana-Farber Cancer Institute

Founded in 1947, Dana-Farber Cancer Institute is committed to providing adults and children with the best treatment available today while developing tomorrow’s cures through cutting-edge research. Based in Boston, Dana-Farber is a teaching affiliate of Harvard Medical School and ranks consistently as one of the top cancer hospitals in the world.

About Clinical.ly

Clinical.ly provides differentiated, cloud-native technology solutions to the clinical research industry, enabling research organizations to conduct studies with greater efficiency and ease. Clinical.ly is dedicated to developing technology that eliminates tedious manual labor, allowing clinical research professionals to focus on patient care.

View original content to download multimedia:https://www.prnewswire.com/news-releases/dana-farber-cancer-institute-partners-with-clinically-to-enhance-regulatory-operations-with-ereg-solutions-302253690.html

SOURCE Clinical.ly

Continue Reading

Technology

Fall Into Creativity with the Monport Laser Fall Sale

Published

on

By

NEW YORK, Sept. 19, 2024 /PRNewswire/ — Experience laser innovation this Fall with Monport Laser, an industry frontrunner in laser engraving and cutting technology, with an exclusive Fall Sale offering incredible discounts and free accessories on a wide range of high-performance laser engraving machines. From September 19th to September 30th, customers can take advantage of this limited-time opportunity to elevate their laser engraving businesses with cutting-edge laser innovation at unbeatable prices.

Monport Laser has been dedicated to providing innovative and reliable laser machines that empower businesses and individuals to achieve their goals. With a focus on quality, precision, and customer satisfaction, Monport Laser has established itself as a trusted leader in the industry. Their commitment to excellence is evident in every laser they produce, ensuring exceptional performance, reliability, and value.

Embrace the Power of CO2 Laser Technology with Exclusive Offers

Monport Laser will offer two free accessories with selected CO2 laser machines during the Monport Fall sale. These versatile lasers are ideal for various applications, including engraving, cutting, and marking wood, acrylic, leather, and more. By taking advantage of this Fall sale, laser engraving businesses can enhance their productivity and expand their creative possibilities.

Experience Unmatched Value with Fiber Laser Discounts

Monport Laser offers substantial discounts of up to $4200 and 3 free accessories on selected models for those seeking the precision and speed of fiber laser technology. Fiber lasers are renowned for their ability to process metals with exceptional efficiency and accuracy, making them indispensable for metal fabrication, manufacturing, and jewelry production. Additionally, customers purchasing fiber lasers during the Fall sale will receive three free accessories, further sweetening the deal.

Elevate Your Desktop Laser Experience with a Free Water Chiller

Monport Laser is committed to providing comprehensive solutions for businesses of all sizes. As part of the Fall sale, customers who purchase the 40W Desktop laser will receive a Free Water Chiller Cw3000. This essential accessory ensures optimal cooling and performance, prolonging the lifespan of the laser and guaranteeing consistent results.

Discover Additional Savings on a Wide Range of Accessories

Monport Laser offers an additional 20% discount on selected accessories to complete your laser setup. From lenses and nozzles to rotary tables and smoke extraction systems, customers can find everything they need to maximize the potential of their laser machines.

Unleash Your Creativity and Productivity

Monport Laser’s Fall sale is the perfect opportunity to invest in laser technology that empowers your business or fuels your creative passions. With exceptional discounts and free accessories, you can acquire the ideal laser solution to meet your needs and budget.

Whether you’re an entrepreneur, artist, or manufacturer, Monport Laser’s advanced laser machines offer unparalleled precision, versatility, and reliability. Take advantage of this limited-time Fall sale and unlock your projects’ full potential for laser innovation.

About Monport Laser

Monport Laser is a global leader in designing, manufacturing, and distributing high-quality laser machines and accessories. With a commitment to innovation and customer satisfaction, Monport Laser provides cutting-edge solutions for various industries, including manufacturing, engraving, marking, and more.

For more information, visit monportlaser.com and follow them on social media for the latest updates.

Website: https://www.monportlaser.com/

 

 

 

View original content:https://www.prnewswire.com/news-releases/fall-into-creativity-with-the-monport-laser-fall-sale-302253699.html

SOURCE Monport Laser

Continue Reading

Technology

MEDIA ADVISORY – Minister Wilkinson to Make a Critical Minerals Infrastructure Announcement

Published

on

By

VANCOUVER, BC, Sept. 19, 2024 /CNW/ – The Honourable Jonathan Wilkinson, Minister of Energy and Natural Resources, and Ranj Pillai, the Premier of Yukon, will make a funding announcement in support of critical minerals infrastructure projects. A media availability will follow.

Date: September 20, 2024

Time: 10:30 a.m. PT

All accredited media are asked to pre-register by emailing media@nrcan-rncan.gc.ca. A dial-in line is available for media and will be provided upon registration.

Follow us on LinkedIn

SOURCE Natural Resources Canada

Continue Reading

Trending